Bauer Business Focus

Houston Startup Tackles Dog Cancer

CAVU Biotherapies researches personalized cancer treatments for dogs and other pets


To embed this piece of audio in your site, please use this code:

<iframe src="" style="height: 115px; width: 100%;"></iframe>
Colleen O’Connor, who has a PhD in toxicology, founded CAVU after losing two dogs to cancer.

There's much talk about curing cancer — especially in Houston, the home of a prestigious cancer center.

But what about cancer in pets?

It is a niche the start-up CAVU Biotherapies, housed in the University of Houston's Innovation Center, wants to fill.

We spoke with CAVU founder Colleen O'Connor for this week's Bauer Business Focus.

Click on the play button above to listen to the interview.

Subscribe to Today in Houston

Fill out the form below to subscribe our new daily editorial newsletter from the HPM Newsroom.

* required


Florian Martin

Florian Martin

Business Reporter

Florian Martin is currently the News 88.7 business reporter. Florian’s stories can frequently be heard on other public radio stations throughout Texas and on NPR nationwide. Some of them have earned him awards from Texas AP Broadcasters, the Houston Press Club, National Association of Real Estate Editors, and Public Radio...

More Information